2 reports

The company is in Phase I clinical trials for ZP-Triptan for the treatment of migraines.

  • Transmucosal Delivery
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.

IT IS ONE OF THE MOST EFFICIENT OF TRIPTANS AND PROVIDES RAPID ONSET OF ACTION.

  • Transmucosal Delivery
  • North America
  • United States
  • Demand
  • Market Size